Latest releases

Apr 22, 2021 ı Press Releases

Vortioxetine significantly improves overall functioning in a global real-world study in Major Depressive Disorder

Apr 13, 2021 ı Corporate Releases

Lundbeck and Otsuka announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer’s-type dementia

View all releases

Q4 / Full Year 2020

Q4 Release

 

Annual Report

 

Webcast

 

Investor Presentation

Clinical Trial Diversity

Explore how Lundbeck is committed to clinical trial diversity, as we strive to improve the quality of life of all people living with brain diseases.

 

Learn more

Join Lundbeck

Current open positions

Browse global vacancies

The Lundbeck Magazine

The Lundbeck Magazine portrays true patient stories to reduce the stigma surrounding people with brain diseases.

 

Read the latest edition

Share price

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.